Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
for Peripheral Artery Disease (PAD)
9 locations incl. Alexander City
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07318610·Phase 3·Recruiting·Listed Jan 2026